UNITED STATES
SECURITIES ANDEXCHANGECOMMISSION WASHINGTON,D.C.20549
FORM 8-K
Pursuant toSection13or15(d)ofTheSecuritiesExchangeActof1934
Date ofreport(Dateofearliesteventreported):September8.2016
Ember Therapeutics,Inc.
(Exact nameofregistrantasspecifiedinitscharter)
| Delaware | 033-13474-NY | 01-3341552 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
135 East 57th Street, 24th Floor New York, NY |
10022 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:(646) 406-6243
___________________________________________________ (Former name or former address, if changed since last report) |
Check theappropriateboxbelowiftheForm8-Kfilingisintended tosimultaneouslysatisfythefilingobligation ofthe registrant under anyofthe followingprovisions (seeGeneral Instruction A.2. below):
[ ]WrittencommunicationspursuanttoRule425undertheSecuritiesAct(17CFR230.425)
[ ]SolicitingmaterialpursuanttoRule14a-12undertheExchangeAct(17CFR240.14a-12)
[ ]Pre-commencementcommunicationspursuanttoRule14d-2(b)undertheExchangeAct(17CFR240.14d-2(b))
[ ] Pre-commencementcommunicationspursuanttoRule13e-4(c)undertheExchangeAct(17CFR240.13e-4(c))
SECTION 1-REGISTRANT’S BUSINESS AND OPERATIONS
Item 1.01 Entry Into A Material Definitive Agreement
On September8,2016,weenteredintoanAssetPurchaseAgreement(the"Agreement")withMidwood Distributors,Inc.,a NewYorkcorporation("MidwoodDistributors").Under theAgreement,we acquired all assets relatedtoDermasilkBrands, a lineof anti-agingskin care products.
Under theAgreement,wehaveacquiredallmaterialassetscurrentlyownedbyDermasilk,includingall inventory,rawmaterials,workinprocess,packaging,thetollfreenumber, hardwareand softwareused for orderingand customersupport, allintellectualproperty, websites,domainnames, accountsreceivableand vendorcredits, contracts,andallmarketingandpromotionalinformationandmaterials.
The purchasepricefortheDermasilkassetsconsistedofcommonstockandwarrants,paidasfollows:
• 2,105,263 sharesofcommon stockatpurchasepriceof$0.95.
In addition,weagreedtoassumecertainliabilitiesofDermasilkarisingundercertaincontractsassumedaspartoftheasset purchase.
SECTION 9 –Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
| Exhibit No. | Description |
| 10.1 | Asset PurchaseAgreement withMidwoodDistributorsInc.forDermasilkBrandandassets |
| 1 |
SIGNATURES
Pursuant totherequirementsoftheSecuritiesExchangeActof1934,theregistranthasdulycausedthisreporttobe signed on its behalfby the undersigned hereunto duly authorized.
Dated:September 26,2016
By:/s/ Joseph Hernandez
Joseph Hernandez
Executive Chairman
| 2 |
